Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03018639
Other study ID # DBT_dropout
Secondary ID
Status Completed
Phase N/A
First received January 9, 2017
Last updated January 11, 2017
Start date December 2012
Est. completion date August 2016

Study information

Verified date January 2017
Source Evangelisches Krankenhaus Bielefeld gGmbH
Contact n/a
Is FDA regulated No
Health authority Ethics Commission: Ethikkommission der Ärztekammer Westfalen-Lippe
Study type Observational

Clinical Trial Summary

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.


Recruitment information / eligibility

Status Completed
Enrollment 89
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- three or more criteria for BPD as defined by DSM-IV (Borderline Personality characteristics; BPC)

Exclusion Criteria:

- inability to contract and consent,

- other severe mental disorders (bipolar disorder, acute psychosis),

- current alcohol,

- illicit or not prescribed drug use,

- simultaneous participation in other treatment studies,

- pregnancy or breastfeeding,

- an inability to negotiate a non-suicide agreement,

- ongoing traumatic contact with the perpetrator, and

- a Body Mass Index < 16.5.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Intervention

Behavioral:
Dialectical Behavior Therapy
DBT is a cognitive-behavioral treatment program that was developed to treat suicidal Patients with BPD (Linehan, 1993).

Locations

Country Name City State
Germany Research Department Bielefeld

Sponsors (1)

Lead Sponsor Collaborator
Evangelisches Krankenhaus Bielefeld gGmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dropout 10 weeks No
See also
  Status Clinical Trial Phase
Completed NCT03384706 - A Comparison of CPT Versus ART Versus WL N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03129204 - Sensation Awareness Focused Training for Spouses N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Completed NCT05113277 - Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Recruiting NCT05843695 - Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Completed NCT00644423 - Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD) N/A
Completed NCT02989987 - NET for SGBV Survivors in Eastern DR Congo N/A
Completed NCT02320799 - Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya N/A
Recruiting NCT02293291 - Thermal Clinic Treatment in Gulf War Illness Phase 1/Phase 2
Completed NCT02242136 - Treatment of Posttraumatic Stress Disorder and Aggressive Behavior in Soldiers and Ex-combatants N/A
Completed NCT02720497 - The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD N/A
Completed NCT01911585 - Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure N/A
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Completed NCT01693978 - Contingency Outcomes in Prolonged Exposure N/A
Completed NCT01469754 - Longitudinal Survey Analysis in Lymphoma Survivors N/A
Completed NCT02362477 - Telemental Health and Cognitive Processing Therapy for Female Veterans With Military-related PTSD Phase 3
Terminated NCT01239173 - Emotional Memory Reactivation in Posttraumatic Stress Disorder Phase 3